Cargando…
Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency
Engineered T cell therapies have revolutionized modern oncology, however processes for manufacturing T cell therapies vary and the impact of manufacturing processes On the cell product is poorly understood. Herein, we have used a commercially available hollow fiber membrane bioreactor (HFMBR) operat...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583081/ https://www.ncbi.nlm.nih.gov/pubmed/34777917 http://dx.doi.org/10.1080/2162402X.2021.1995168 |